Wakamoto Pharmaceutical Co.,Ltd. (WAKAMOTO PHARMACEUTICAL CO) Aktie
4512.T
WAKAMOTO PHARMACEUTICAL CO
Market Cap
$9,231,765,504
Über Wakamoto Pharmaceutical Co.,Ltd. (WAKAMOTO PHARMACEUTICAL CO) Aktie
Wakamoto Pharmaceutical Co.,Ltd. engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Unternehmensinformationen
103-8330 Tokyo, Japan
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.